Edition:
United Kingdom

SINOPHARM GROUP CO LTD (1099.HK)

1099.HK on Hong Kong Stock

33.20HKD
23 Feb 2018
Change (% chg)

HK$0.30 (+0.91%)
Prev Close
HK$32.90
Open
HK$32.80
Day's High
HK$33.35
Day's Low
HK$32.65
Volume
2,713,532
Avg. Vol
5,719,989
52-wk High
HK$37.85
52-wk Low
HK$29.85

Latest Key Developments (Source: Significant Developments)

Sinopharm Group Co's Board Resolves To Propose Issue Of Corporate Bonds In China
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::BOARD RESOLVED TO PROPOSE ISSUE OF CORPORATE BONDS IN PRC; ISSUE SIZE OF NO MORE THAN RMB10 BILLION.  Full Article

Virtual Incision Announces $18 Mln Series B Funding For Miniaturized Surgical Robots
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Virtual Incision Corp::VIRTUAL INCISION ANNOUNCES $18 MILLION SERIES B FUNDING FOR MINIATURIZED SURGICAL ROBOTS.VIRTUAL INCISION CORPORATION - SERIES B FUNDING ROUND WAS CO-LED BY SINOPHARM CAPITAL & BLUESTEM CAPITAL.  Full Article

Sinopharm Group Says To Acquire Pudong Medicines And Herbs
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::‍CO TO ACQUIRE 100% EQUITY INTEREST IN PUDONG MEDICINES AND HERBS FROM CHINA NATIONAL PHARMACEUTICAL GROUP CORP FOR RMB217.5 MILLION.  Full Article

China Vanguard You Champion says through unit enters into joint venture deal with Sino-TCM
Friday, 24 Nov 2017 

Nov 24 (Reuters) - China Vanguard You Champion Holdings Ltd <8156.HK> ::‍Co through its unit enters into a joint venture agreement with Sinopharm Traditional Chinese Medicine Co..  Full Article

Sinopharm Group says Li Zhiming proposes to cease to serve as president​
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::Li Zhiming proposed to cease to serve as president​.‍Li zhiming continues to serve as chairman of board​.‍Liu yong ceased to serve as vice president​.‍Board resolved to appoint liu yong as president of company​.  Full Article

Sinopharm Group posts ‍9-mnth profit attributable of RMB ‍3.66​ billion​
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Sinopharm Group Co Ltd <1099.HK>:9-month net profit attributable to equity holders of co RMB ‍3.66​ billion versus RMB3.60 billion.‍9-mnth total operating revenue RMB208.63 billion versus RMB193.10 billion ​.  Full Article

Sinopharm Group Co Ltd posts HY profit attributable rmb2.76 billion
Monday, 28 Aug 2017 

Aug 28 (Reuters) - Sinopharm Group Co Ltd <1099.HK>:HY profit attributable to owners of parent RMB2.76 billion versus RMB2.53 billion.HY revenue RMB 137.77 billion versus RMB 126.80 billion.  Full Article

Sinopharm posts half-year net profit of RMB 2.53 billion<1099.HK>
Monday, 22 Aug 2016 

Sinopharm Group Co Ltd <1099.HK>: Announcement on 2016 interim results <1099.HK> . Says no interim dividend was proposed for the six-month period ended 30 June 2016 . HY profit attributable to owners of the parent RMB 2.53 billion versus RMB 1.91 billion . Says HY revenue RMB 125.89 billion versus RMB 111.06 billion . The group has sufficient financial resources for ongoing operation in the foreseeable future" .  Full Article

Sinopharm updates on proposed adoption of restricted share incentive scheme<1099.HK>
Friday, 19 Aug 2016 

Sinopharm Group Co Ltd <1099.HK>: Announcement proposed adoption of restricted share incentive scheme <1099.HK> . Proposes to adopt the scheme to closely align the interests and benefits of and risks sharing among the shareholders, the company and the employees .  Full Article

Sinopharm updates on participation in pilot works of developing mixed-ownership economy<1099.HK>
Thursday, 18 Aug 2016 

Sinopharm Group Co Ltd <1099.HK>: Informed that CNPGC has obtained the "approval on implementation of share incentive scheme of Sinopharm Group Co Ltd" . Approval from the state-owned assets supervision and administration commission of the state council .  Full Article

HK stocks rally on easing US rate fears; China inches up despite Anbang jolt

* HK->Shanghai Connect daily quota used 6.5 pct, Shanghai->HK daily quota used 7.4 pct